drugset / Trial / NCT02123017

Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy

NCT02123017

Phase 2 Completed 32 enrolled Cumberland Pharmaceuticals
Non-randomizedSingle-groupSingle-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy and safety of bisacodyl combined with escalating doses of lactulose to be used as a preparation for colonoscopy.

Timeline

Start
2014-04
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisacodyl Small molecule 15 mg
Subject Lactulose Other / unclassified 90 g
Subject Lactulose Other / unclassified 135 g
Subject Lactulose Other / unclassified 180 g

Indications

No indication recorded.